Spectrum News: Therapies make psychedelics more accessible
UC researcher says decriminalization is a good step
Spectrum News turned to a University of Cincinnati researcher to explain the potential therapeutic benefits psychedelics could offer some people.
UC College of Arts and Sciences postdoctoral researcher Neşe Devenot told Spectrum News that people have had meaningful, transformative experiences using psychedelics such as psilocybin, the compound in magic mushrooms.
UC postdoctoral researcher Neşe Devenot. Photo/Andrew Higley/UC Marketing + Brand
Devenot works in UC's Institute for Research in Sensing, which explores sensing and sensor technology from both scientific and artistic perspectives.
Federal lawmakers have proposed legislation to expand access to psychedelic substances for medical purposes.
Devenot said psychedelics are getting more research attention.
“Some researchers look at this specifically as an experiential medicine, that there’s something about the experience that is therapeutic. That’s debated,” she told Spectrum News.
The Drug Enforcement Agency categorizes some psychedelics as Schedule I drugs, which criminalizes their use. Meanwhile, pharmaceutical companies are pursuing new medical treatments based on psychedelics.
Devenot said decriminalization would be a good step. Some studies have shown positive benefits to psychedelics for treatment of post-traumatic stress disorder or depression.
“Pyschedelics might help you get outside of those ruminative, fixated thought patterns to free you up to see yourself and your problems and relationship to the world in a different way,” Devenot said. “I think there's some truth to that.”
Watch the Spectrum News story.
Learn more about Devenot's work.
Featured image at top: UC postdoctoral researcher Neşe Devenot talked to Spectrum News about new legislation that could open up medical uses of psychedelics. Photo/Andrew Higley/
UC Marketing + Brand
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.